Literature DB >> 16100003

Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy.

Donald G Phinney1, Katy Hill, Charles Michelson, Maria DuTreil, Catherine Hughes, Sally Humphries, Robin Wilkinson, Melody Baddoo, Erica Bayly.   

Abstract

We used serial analysis of gene expression to catalog the transcriptome of murine mesenchymal stem cells (MSCs) enriched from bone marrow by immunodepletion. Interrogation of this database, results of which are delineated in the appended databases, revealed that immunodepleted murine MSCs (IDmMSCs) highly express transcripts encoding connective tissue proteins and factors modulating T-cell proliferation, inflammation, and bone turnover. Categorizing the transcriptome based on gene ontologies revealed the cells also expressed mRNAs encoding proteins that regulate mesoderm development or that are characteristic of determined mesenchymal cell lineages, thereby reflecting both their stem cell nature and differentiation potential. Additionally, IDmMSCs also expressed transcripts encoding proteins regulating angiogenesis, cell motility and communication, hematopoiesis, immunity and defense as well as neural activities. Immunostaining and fluorescence-activated cell sorting analysis revealed that expression of various regulatory proteins was restricted to distinct subpopulations of IDmMSCs. Moreover, in some cases, these proteins were absent or expressed at reduced levels in other murine MSC preparations or cell lines. Lastly, by comparing their transcriptome to that of 17 other murine cell types, we also identified 43 IDmMSC-specific transcripts, the nature of which reflects their varied functions in bone and marrow. Collectively, these results demonstrate that IDmMSC express a diverse repertoire of regulatory proteins, which likely accounts for their demonstrated efficacy in treating a wide variety of diseases. The restricted expression pattern of these proteins within populations suggests that the cellular composition of marrow stroma and its associated functions are more complex than previously envisioned.

Entities:  

Mesh:

Year:  2005        PMID: 16100003     DOI: 10.1634/stemcells.2004-0236

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  29 in total

1.  Molecular analysis of the differentiation potential of murine mesenchymal stem cells from tissues of endodermal or mesodermal origin.

Authors:  Claudia Concer Viero Nora; Melissa Camassola; Bruno Bellagamba; Nilo Ikuta; Ana Paula Christoff; Lindolfo da Silva Meirelles; Raquel Ayres; Rogério Margis; Nance Beyer Nardi
Journal:  Stem Cells Dev       Date:  2011-11-22       Impact factor: 3.272

Review 2.  Therapeutic window, a critical developmental stage for stem cell therapies.

Authors:  Shengwen Calvin Li; Yuan-Ping Han; Brent A Dethlefs; William G Loudon
Journal:  Curr Stem Cell Res Ther       Date:  2010-12       Impact factor: 3.828

Review 3.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

Review 4.  Mesenchymal progenitor cell research: limitations and recommendations.

Authors:  Ross Summer; Alan Fine
Journal:  Proc Am Thorac Soc       Date:  2008-08-15

Review 5.  The origins of mesenchymal stromal cell heterogeneity.

Authors:  Meirav Pevsner-Fischer; Sarit Levin; Dov Zipori
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

6.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

7.  Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels.

Authors:  Wen-Tzu Lai; Veena Krishnappa; Donald G Phinney
Journal:  Stem Cells       Date:  2011-07       Impact factor: 6.277

8.  Isolation of murine bone marrow derived mesenchymal stem cells using Twist2 Cre transgenic mice.

Authors:  Yaling Liu; Liping Wang; Reza Fatahi; Mark Kronenberg; Ivo Kalajzic; David Rowe; Yingcui Li; Peter Maye
Journal:  Bone       Date:  2010-07-27       Impact factor: 4.398

Review 9.  A SAGE View of Mesenchymal Stem Cells.

Authors:  Donald G Phinney
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

10.  Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury.

Authors:  Luis A Ortiz; Maria Dutreil; Cheryl Fattman; Amitabh C Pandey; German Torres; Kristina Go; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.